Delivery Order SPE2DR25D3301-SPE2DR26F19ZD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,043.64 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,840.08 for Adderall XR 20 mg capsules (100-count) on December 29, 2025, with completion expected by December 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,856.10 on December 17, 2025, for the supply of Adderall XR 20 mg capsules (100-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.09 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (quantity: 100s) on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,146.35 for Adderall XR 20 mg capsules (100 count) on June 2, 2025, with completion scheduled for June 3, 2025. This contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's significantly larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,105.08 to AmerisourceBergen Drug Corp for Adderall XR 30 mg capsules (100 count) on December 3, 2025, with completion due by December 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,466.79 delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.54 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19ZDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,959.36 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed price contract type. The award was made on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing contract vehicle. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of medications and medical commodities to support military and veteran healthcare systems. The company's substantial IDC with DLA reflects its established capability to fulfill federal pharmaceutical needs across multiple therapeutic domains, with the Adderall XR delivery representing a routine order fulfillment from this larger prime vendor contract supporting Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/28/25 |